Tango Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNGX and other ETFs, options, and stocks.

About TNGX

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need.

CEO

Barbara L. Weber

CEOBarbara L. Weber

Employees

155

Employees155

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2017

Founded2017

Employees

155

Employees155

TNGX Key Statistics

Market cap

204.32M

Market cap204.32M

Price-Earnings ratio

-1.56

Price-Earnings ratio-1.56

Dividend yield

—

Dividend yield—

Average volume

4.78M

Average volume4.78M

High today

$1.85

High today$1.85

Low today

$1.84

Low today$1.84

Open price

$2.07

Open price$2.07

Volume

7.47K

Volume7.47K

52 Week high

$12.02

52 Week high$12.02

52 Week low

$1.03

52 Week low$1.03

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TNGX. This list is generated using Robinhood data, and it’s not a recommendation.